Package 67751-119-01
Brand: excedrin extra strength pain reliever
Generic: acetaminophen, aspirin (nsaid), and caffeinePackage Facts
Identity
Package NDC
67751-119-01
Digits Only
6775111901
Product NDC
67751-119
Description
1 POUCH in 1 CARTON (67751-119-01) / 2 TABLET, FILM COATED in 1 POUCH
Marketing
Marketing Status
Brand
excedrin extra strength pain reliever
Generic
acetaminophen, aspirin (nsaid), and caffeine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "239668fa-359b-fe6e-e063-6394a90a98af", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["209468", "308297"], "spl_set_id": ["f7e572e9-82a7-2127-e053-6394a90ab01a"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Navajo Manufacturing Company Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (67751-119-01) / 2 TABLET, FILM COATED in 1 POUCH", "package_ndc": "67751-119-01", "marketing_start_date": "20190315"}, {"sample": false, "description": "2 POUCH in 1 CARTON (67751-119-02) / 2 TABLET, FILM COATED in 1 POUCH", "package_ndc": "67751-119-02", "marketing_start_date": "20190315"}], "brand_name": "Excedrin Extra Strength Pain Reliever", "product_id": "67751-119_239668fa-359b-fe6e-e063-6394a90a98af", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "67751-119", "generic_name": "Acetaminophen, Aspirin (NSAID), and Caffeine", "labeler_name": "Navajo Manufacturing Company Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Excedrin", "brand_name_suffix": "Extra Strength Pain Reliever", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20190315", "listing_expiration_date": "20261231"}